clioquinol and olsalazine

clioquinol has been researched along with olsalazine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Arsequell, G; Blasi, D; Busquets, MA; Cardoso, I; Cotrina, EY; Gales, L; Gimeno, A; Jiménez-Barbero, J; Leite, JP; Liz, MA; Llop, J; Planas, A; Prohens, R; Quintana, J; Rivas, J; Santos, LM	1

Other Studies

2 other study(ies) available for clioquinol and olsalazine

Article	Year
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Targeting transthyretin in Alzheimer's disease: Drug discovery of small-molecule chaperones as disease-modifying drug candidates for Alzheimer's disease. European journal of medicinal chemistry, 2021, Dec-15, Volume: 226 Topics: Alzheimer Disease; Calorimetry; Dose-Response Relationship, Drug; Drug Discovery; Humans; Models, Molecular; Molecular Chaperones; Molecular Structure; Prealbumin; Small Molecule Libraries; Software; Structure-Activity Relationship	2021

Article

Year

Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.

Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

Topics:

2008

Targeting transthyretin in Alzheimer's disease: Drug discovery of small-molecule chaperones as disease-modifying drug candidates for Alzheimer's disease.

European journal of medicinal chemistry, 2021, Dec-15, Volume: 226

Topics: Alzheimer Disease; Calorimetry; Dose-Response Relationship, Drug; Drug Discovery; Humans; Models, Molecular; Molecular Chaperones; Molecular Structure; Prealbumin; Small Molecule Libraries; Software; Structure-Activity Relationship

2021